ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Takeda to sell assets in Asia Pacific to Celltrion for $266m pharmaceutical-technology
June 15, 2020Takeda Pharmaceutical has signed an agreement to sell certain non-core over-the-counter (OTC) and prescription pharmaceutical assets available only in the Asia Pacific to South Korean biopharmaceutical firm Celltrion for $266m in an upfront payment.
Pharma Sources Insight January 2025
